Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Stupin Polančec, Darija"'
Autor:
Stupin Polančec, Darija1 (AUTHOR) info@onkolab.hr, Homar, Sonja2 (AUTHOR) shomar@student.pharma.hr, Jakšić, Daniela3 (AUTHOR) daniela.jaksic@pharma.unizg.hr, Kopjar, Nevenka4 (AUTHOR) nkopjar@imi.hr, Šegvić Klarić, Maja3 (AUTHOR) maja.segvic@pharma.unizg.hr, Dabelić, Sanja2 (AUTHOR) maja.segvic@pharma.unizg.hr
Publikováno v:
Toxins. Jul2024, Vol. 16 Issue 7, p321. 13p.
Publikováno v:
Acta Pharmaceutica, Vol 72, Iss 2, Pp 275-288 (2022)
The Madin-Darby canine kidney (MDCK) cell line is frequently used for permeability screening in drug discovery. It contains endogenous transporters, most prominently canine multidrug resistance P-glycoprotein (Mdr1), which can interfere with studies
Externí odkaz:
https://doaj.org/article/d04d9511221d4d84b64c1374aeb5fd7f
Autor:
Pernar Kovač, Margareta, Tadić, Vanja, Kralj, Juran, Duran, George E., Stefanelli, Alessia, Stupin Polančec, Darija, Dabelić, Sanja, Bačić, Niko, Tomicic, Maja T., Heffeter, Petra, Sikic, Branimir I., Brozovic, Anamaria
Publikováno v:
Cellular & Molecular Life Sciences; Oct2023, Vol. 80 Issue 10, p1-19, 19p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Acta Pharmaceutica, Vol 72, Iss 2, Pp 275-288 (2022)
Acta Pharmaceutica
Volume 72
Issue 2
Acta Pharmaceutica
Volume 72
Issue 2
The Madin-Darby canine kidney (MDCK) cell line is frequently used for permeability screening in drug discovery. It contains endogenous transporters, most prominently canine multidrug resistance P-glycoprotein (Mdr1), which can interfere with studies
Autor:
Pernar Kovač, Margareta, Tadić, Vanja, Kralj, Juran, Stupin Polančec, Darija, Dabelić, Sanja, Tomicic, Maja, Brozovic, Anamaria
Acquired drug resistance remains a major problem for successful chemotherapy, contributing to poor long-term prognosis of ovarian cancer (OC) patients. The combination of platinum drugs and taxanes is commonly used to treat patients with OC, due to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::e86743aae0f2ffbc66661fed9a6c4d2d
https://www.bib.irb.hr/1234701
https://www.bib.irb.hr/1234701
Autor:
Kralj, Juran, Pernar Kovač, Margareta, Dabelić, Sanja, Stupin Polančec, Darija, Wachmeister, Thorsten, Köhrer, Karl, Brozović, Anamaria
Despite the notable progress in the development of new technologies and methods for early tumor diagnostic, ovarian cancer is still the deadliest gynecological disease worldwide. Lack of early- stage symptoms and specific biomarkers results in late-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::0a37b9a0ad89ca9b207c88ce9669c38e
https://www.bib.irb.hr/1235989
https://www.bib.irb.hr/1235989
Autor:
Pernar Kovač, Margareta, Tadić, Vanja, Kralj, Juran, Duran, George E., Stefanelli, Alessia, Stupin Polančec, Darija, Dabelić, Sanja, Bačić, Niko, Tomicic, Maja, Heffeter, Petra, Sikic, Branimir I., Brozovic, Anamaria
Ovarian cancer (OC) is the seventh most common cancer type in women worldwide. Unfortunately, lack of early detection methods leads to diagnosis of already advanced disease tied with highest fatality-to case ratio among gynecological malignancies. Co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::71c751033b801f70cf915cc5ec90964f
https://www.bib.irb.hr/1234712
https://www.bib.irb.hr/1234712
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Acta Pharmaceutica; June 2022, Vol. 72 Issue: 2 p275-288, 14p